EMA OKs two new drugs — J&J's BCMA CAR-T for multiple myeloma, AstraZeneca's Evusheld — plus 5 label expansions
The European Medicines Agency’s CHMP on Friday recommended two new drugs for approval, AstraZeneca’s Evusheld to help prevent Covid-19, and Johnson …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
